The trial will enrol around 40 advanced melanoma patients at up to 18 clinical sites in the UK, Italy, France and Spain. Credit: Evgeniy Kalinovskiy/Shutterstock ...
In addition to CIDP indication, the asset is also being assessed for inflammatory bowel disease, rheumatoid arthritis, and non-alcoholic steatohepatitis. Credit: PeopleImages.com – Yuri A/Shutterstock ...
Pharma Technology Focus is free to read on all devices. Subscribe to Pharma Technology Focus and never miss an issue. Whether you want to increase brand awareness, deliver a complex message or launch ...